Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, indicating a site release rather than a substantive change to the trial record.
    Difference
    0.1%
    Check dated 2026-04-25T18:45:12.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:37:14.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T01:05:54.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. No visible changes to study details, eligibility criteria, or locations.
    Difference
    0.1%
    Check dated 2026-03-06T18:31:17.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2; this is a minor platform update with no changes to study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:20:41.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    - Revision: v3.4.1 added; Revision: v3.4.0 removed.
    Difference
    0.1%
    Check dated 2026-02-06T09:22:12.000Z thumbnail image

Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.